Table 1

 Characteristics of patients at the time of the FibroScan examination

All patients (n = 711)Patients with liver biopsy (n = 354)F3F4 fibrosis patients (n = 144)
Results are given as mean (SD) or *n (%).
BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyl-transpeptidase; US ultrasonographic.
Males (%)*403 (57)206 (58)102 (71)
Age (y)52 (13)50 (13)53 (12)
BMI (kg/m2)24.2 (4.2)24.5 (4.3)25.2 (4.3)
AST (UI/l)59.5 (86.1)71.3 (110.5)94.7 (138.7)
ALT (UI/l)79.2 (108.3)82.7 (106.6)108.1 (119.1)
GGT (UI/l)136 (245)159 (229)206 (272)
Total bilirubin (μmol/l)16.9 (31.5)19.7 (37.3)27.3 (44)
Platelet count (G/l)209 (87)213 (91)165 (83)
Prothrombin time (%)90 (14)89 (15)82 (17)
Factor V (%)88.6 (18.5)92.5 (15)80.5 (20.5)
Albumin (g/l)38.5 (5.6)38.5 (5.2)36.1 (6.3)
α Fetoprotein (ng/ml)49 (456)31 (105)54 (270)
Fibrosis score (%)*
    No or mild fibrosis111 (31)
    Moderate fibrosis99 (28)
    Severe fibrosis49 (14)
    Cirrhosis95 (27)
Past history of ascites*18 (13)
Past history of bleeding varices*14 (10)
Hepatocellular carcinoma*19 (13)
Oesophageal varices stage 2/3*42 (29)
US splenomegaly*48 (33)